Outcomes of cavotricuspid isthmus-dependent flutter ablation: randomized study comparing single vs. multiple catheter procedures-the SIMPLE study.


Journal

Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing
ISSN: 1572-8595
Titre abrégé: J Interv Card Electrophysiol
Pays: Netherlands
ID NLM: 9708966

Informations de publication

Date de publication:
Dec 2023
Historique:
received: 21 11 2022
accepted: 14 02 2023
medline: 5 12 2023
pubmed: 7 3 2023
entrez: 6 3 2023
Statut: ppublish

Résumé

Catheter ablation is recommended as first-line therapy for patients with symptomatic typical AFl. Although the conventional multi-catheter approach is the standard of care for cavotricuspid isthmus (CTI) ablation, a single-catheter approach was recently described as a feasible alternative. The present study sought to compare safety, efficacy, and efficiency of single vs. multi-catheter approach for atrial flutter (AFl) ablation. In this randomized multi-center study, consecutive patients referred for AFl ablation (n = 253) were enrolled and randomized to multiple vs. single-catheter approach for CTI ablation. In the single-catheter arm, PR interval (PRI) on the surface ECG was used to prove CTI block. Procedural and follow-up data were collected and compared between the two arms. 128 and 125 patients were assigned to the single-catheter and to the multi-catheter arms, respectively. In the single-catheter arm, procedure time was significantly shorter (37 ± 25 vs. 48 ± 27 minutes, p = 0.002) and required less fluoroscopy time (430 ± 461 vs. 712 ± 628 seconds, p < 0.001) and less radiofrequency time (428 ± 316 vs. 643 ± 519 seconds, p < 0.001), achieving a higher first-pass CTI block rate (55 (45%) vs. 37 (31%), p = 0.044), compared with the multi-catheter arm. After a median follow-up of 12 months, 11 (4%) patients experienced AFl recurrences (5 (4%) in the single-catheter arm and 6 (5%) in the multi-catheter arm, p = 0.99). No differences were found in arrhythmia-free survival between arms (log-rank = 0.71). The single-catheter approach for typical AFl ablation is not inferior to the conventional multiple-catheter approach, reducing procedure, fluoroscopy, and radiofrequency time.

Sections du résumé

BACKGROUND BACKGROUND
Catheter ablation is recommended as first-line therapy for patients with symptomatic typical AFl. Although the conventional multi-catheter approach is the standard of care for cavotricuspid isthmus (CTI) ablation, a single-catheter approach was recently described as a feasible alternative. The present study sought to compare safety, efficacy, and efficiency of single vs. multi-catheter approach for atrial flutter (AFl) ablation.
METHODS METHODS
In this randomized multi-center study, consecutive patients referred for AFl ablation (n = 253) were enrolled and randomized to multiple vs. single-catheter approach for CTI ablation. In the single-catheter arm, PR interval (PRI) on the surface ECG was used to prove CTI block. Procedural and follow-up data were collected and compared between the two arms.
RESULTS RESULTS
128 and 125 patients were assigned to the single-catheter and to the multi-catheter arms, respectively. In the single-catheter arm, procedure time was significantly shorter (37 ± 25 vs. 48 ± 27 minutes, p = 0.002) and required less fluoroscopy time (430 ± 461 vs. 712 ± 628 seconds, p < 0.001) and less radiofrequency time (428 ± 316 vs. 643 ± 519 seconds, p < 0.001), achieving a higher first-pass CTI block rate (55 (45%) vs. 37 (31%), p = 0.044), compared with the multi-catheter arm. After a median follow-up of 12 months, 11 (4%) patients experienced AFl recurrences (5 (4%) in the single-catheter arm and 6 (5%) in the multi-catheter arm, p = 0.99). No differences were found in arrhythmia-free survival between arms (log-rank = 0.71).
CONCLUSIONS CONCLUSIONS
The single-catheter approach for typical AFl ablation is not inferior to the conventional multiple-catheter approach, reducing procedure, fluoroscopy, and radiofrequency time.

Identifiants

pubmed: 36877415
doi: 10.1007/s10840-023-01511-1
pii: 10.1007/s10840-023-01511-1
doi:

Types de publication

Randomized Controlled Trial Multicenter Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1979-1988

Informations de copyright

© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Références

Da Costa A, The ́venin J, Roche F, et al. Results from the Loire-Arde`che-Droˆme-Ise`re-Puy-de-Doˆme (LADIP) trial on atrial flutter, a multicentric prospective randomized study comparing amiodarone and radiofrequency ablation after the first episode of symptomatic atrial flutter. Circulation. 2006;114:1676–81.
doi: 10.1161/CIRCULATIONAHA.106.638395 pubmed: 17030680
Page RL, Joglar JA, Caldwell MA, et al. 2015 ACC/AHA/HRS guideline for the management of adult patients with supraventricular tachycardia: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Circulation. 2016;133:e506–74.
pubmed: 26399663
Madaffari A, Krisai P, Spies F, et al. Ablation of typical atrial flutter guided by the paced PR interval on the surface electrocardiogram: a proof of concept study. Europace. 2019;21:1750–4.
doi: 10.1093/europace/euz208 pubmed: 31384937
Brugada J, Katritsis DG, Arbelo E, et al. ESC Scientific Document Group. 2019 ESC guidelines for the management of patients with supraventricular tachycardia the task force for the management of patients with supraventricular tachycardia of the European Society of Cardiology (ESC). Eur Heart J. 2020;41(5):655–720.
doi: 10.1093/eurheartj/ehz467 pubmed: 31504425
Cosio FG, Lopez-Gil M, Goicolea A, et al. Radiofrequency ablation of the inferior vena cava-tricuspid valve isthmus in common atrial flutter. Am J Cardiol. 1993;71:705–9.
doi: 10.1016/0002-9149(93)91014-9 pubmed: 8447269
Feld GK, Fleck RP, Chen PS, et al. Radiofrequency catheter ablation for the treat- ment of human type 1 atrial flutter: identification of a critical zone in the re-entrant circuit by endocardial mapping techniques. Circulation. 1992;86:1233–40.
doi: 10.1161/01.CIR.86.4.1233 pubmed: 1394929
Spector P, Reynolds MR, Calkins H, et al. Meta-analysis of ablation of atrial flutter and supraventricular tachycardia. Am J Cardiol. 2009;104:671–7.
doi: 10.1016/j.amjcard.2009.04.040 pubmed: 19699343
Laurent G, Bourcier A, Bertaux G, et al. A new and simple method for distinguishing complete from incomplete block through the cavotricuspid isthmus. J Interv Card Electrophysiol. 2005;14:175–82.
doi: 10.1007/s10840-006-6085-5 pubmed: 16421694
Sebag FA, Simeon E, Moubarak G, et al. Definition of success criteria for ablation of typical right atrial flutter with a single-catheter approach: a pilot study. Arch Cardiovasc Dis. 2020;113:791–6.
doi: 10.1016/j.acvd.2020.05.021 pubmed: 33051170
König S, Ueberham L, Schuler E, Wiedemann M, Reithmann C, Seyfarth M, Sause A, Tebbenjohanns J, Schade A, Shin DI, Staudt A, Zacharzowsky U, Andrié R, Wetzel U, Neuser H, Wunderlich C, Kuhlen R, Tijssen JGP, Hindricks G, Bollmann A. In-hospital mortality of patients with atrial arrhythmias: insights from the German-wide Helios hospital network of 161 502 patients and 34 025 arrhythmia-related procedures. Eur Heart J. 2018;39:3947–57.
doi: 10.1093/eurheartj/ehy528 pubmed: 30165430
Falasconi G, Penela D, Soto-Iglesias D, et al. A standardized stepwise zero-fluoroscopy approach with transesophageal echocardiography guidance for atrial fibrillation ablation . J Interv Card Electrophysiol. 2021;10.
Pambrun T, Combes S, Sousa P, et al. Contact-force guided single-catheter approach for pulmonary vein isolation: feasibility, outcomes, and cost-effectiveness. Heart Rhythm. 2017;14:331–8.
doi: 10.1016/j.hrthm.2016.12.008 pubmed: 27940124
Heidbuchel H, Wittkampf FH, Vano E, et al. Practical ways to reduce radiation dose for patients and staff during device implantations and electrophysiological procedures. Europace. 2014;16:946–64.
doi: 10.1093/europace/eut409 pubmed: 24792380
Lickfett L, Mahesh M, Vasamreddy C, et al. Radiation exposure during catheter ablation of atrial fibrillation. Circulation. 2004;110:3003–10.
doi: 10.1161/01.CIR.0000146952.49223.11 pubmed: 15505084

Auteurs

Diego Penela (D)

Heart Institute, Teknon Medical Center, C/ Vilana, 12, Barcelona, 08022, Spain.

Alfredo Chauca (A)

Heart Institute, Teknon Medical Center, C/ Vilana, 12, Barcelona, 08022, Spain.

Juan Fernández-Armenta (J)

Puerta del Mar University Hospital, Cádiz, Spain.

Ricardo Pavón (R)

Hospital Universitario Virgen de Valme, Sevilla, Spain.

Begoña Benito (B)

Hospital Vall d'Hebron, Barcelona, Spain.

Juan Acosta (J)

Virgen del Rocío University Hospital, Sevilla, Spain.

Jose Miguel Lozano (JM)

Hospital Universitario Clínico San Cecilio, Granada, Spain.

Giulio Falasconi (G)

Heart Institute, Teknon Medical Center, C/ Vilana, 12, Barcelona, 08022, Spain.
Campus Clínic, University of Barcelona, Barcelona, Spain.

Rodolfo San Antonio (R)

Heart Institute, Teknon Medical Center, C/ Vilana, 12, Barcelona, 08022, Spain.

David Soto-Iglesias (D)

Heart Institute, Teknon Medical Center, C/ Vilana, 12, Barcelona, 08022, Spain.

Julio Martí-Almor (J)

Heart Institute, Teknon Medical Center, C/ Vilana, 12, Barcelona, 08022, Spain.

Augusto Ordoñez (A)

Heart Institute, Teknon Medical Center, C/ Vilana, 12, Barcelona, 08022, Spain.

Aldo Bellido (A)

Heart Institute, Teknon Medical Center, C/ Vilana, 12, Barcelona, 08022, Spain.

José Miguel Carreño (JM)

Hospital Universitario Virgen de Valme, Sevilla, Spain.

Maria Matiello (M)

Hospital Universitario General de Cataluña, Barcelona, Spain.

Lucas Cano (L)

Puerta del Mar University Hospital, Cádiz, Spain.

Alonso Pedrote (A)

Virgen del Rocío University Hospital, Sevilla, Spain.

Daniel Viveros (D)

Heart Institute, Teknon Medical Center, C/ Vilana, 12, Barcelona, 08022, Spain.
Campus Clínic, University of Barcelona, Barcelona, Spain.

Jose Alderete (J)

Heart Institute, Teknon Medical Center, C/ Vilana, 12, Barcelona, 08022, Spain.
Campus Clínic, University of Barcelona, Barcelona, Spain.

Pietro Francia (P)

Heart Institute, Teknon Medical Center, C/ Vilana, 12, Barcelona, 08022, Spain.
Cardiology, Department of Clinical and Molecular Medicine, St. Andrea Hospital, Sapienza, Rome, Italy.

Maria Algarra-Cullell (M)

Hospital Universitario Clínico San Cecilio, Granada, Spain.

Etelvino Silva (E)

Puerta del Mar University Hospital, Cádiz, Spain.

Julia Meca-Santamaria (J)

Heart Institute, Teknon Medical Center, C/ Vilana, 12, Barcelona, 08022, Spain.

Paula Franco (P)

Heart Institute, Teknon Medical Center, C/ Vilana, 12, Barcelona, 08022, Spain.

Riccardo Cappato (R)

IRCCS Multimedica Group, Sesto San Giovanni, Italy.

Antonio Berruezo (A)

Heart Institute, Teknon Medical Center, C/ Vilana, 12, Barcelona, 08022, Spain. antonio.berruezo@quironsalud.es.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH